Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
05/2003
05/14/2003CN1416837A Bone Bi-syndrome treating pill
05/14/2003CN1416834A Medicine for treating dental diseases
05/14/2003CN1416827A Technological process of extracting bee venom
05/14/2003CN1416826A Cancer-treating medicine and its prepn
05/14/2003CN1416825A Active earthworm decoction and its prepn
05/14/2003CN1416824A Medicament for preventing and treating myopia and asthenopia
05/14/2003CN1416823A Medicine composition for treating osteoporosis
05/14/2003CN1416822A Nano freshwater mussel mineral Chinese medicine and its prepn process
05/14/2003CN1416821A Nanometer level pearl product and its prepn process
05/14/2003CN1416820A Nanometer level pilose antler and pilose antler product and their prepn process
05/14/2003CN1416722A Royal jelly mate
05/14/2003CN1108168C Chinese medicine preparation for treating angina pectoris and its dispensation process
05/14/2003CN1108166C Anti-inflammation analgesic
05/14/2003CN1108165C Traditional Chinese medicinal preparation for treating cancer
05/14/2003CN1108162C Men's tonic wine and its preparation method
05/14/2003CN1108161C Yichun wine and its preparation method
05/14/2003CN1108160C Medicine for curing stomatocace and its preparation method
05/14/2003CN1108159C Traditional Chinese medicine for curing diabetes and kidney deficiency
05/14/2003CN1108158C Analgesic composition
05/14/2003CN1108152C Rapamycin formulations for oral administration
05/14/2003CN1108114C Process for preparing antelope-fish brain beverage and its product
05/13/2003US6562799 DNA binding proteins that are modified such that they are stable under non-hypoxic as well as hypoxic conditions
05/13/2003US6562619 Genration of preferential cell pools; prepare nutrient broth containing growth factor, inoculate with cells, propagate cells, recover cells
05/13/2003US6562597 Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses
05/13/2003US6562377 Composition to stop hairloss
05/13/2003US6562358 Nontoxic vernix compositions and method of producing
05/13/2003US6562345 Immuno-reactive peptide CTL epitopes of human cytomegalovirus
05/13/2003US6562344 Nitrosylation of protein SH groups and amino acid residues as a therapeutic modality
05/13/2003US6562336 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
05/13/2003CA2315877C Facilitated oxygen delivery in conjunction with hemodilution
05/13/2003CA2258211C Multiple element filter
05/13/2003CA2127114C A composition for the biological stimulation and correction of the phenotype of an organism and a method for treating the same
05/09/2003CA2406687A1 Chimeric promoters for controlling expression in muscle cells
05/08/2003WO2003038090A1 Method of inducing diffrentiation of immortalized mesodermal stem cells into nervous system cells
05/08/2003WO2003038076A1 Immortalized mesenchymal cells and utilization thereof
05/08/2003WO2003038075A1 Method of inducing differentiation of mesodermal stem cells, es cells or immortalized cells into nervous system cells
05/08/2003WO2003038074A1 Method of inducing differentiation of mesoblast stem cells or es cells into nerve system cells
05/08/2003WO2003038073A2 Method for enhancing keratinocyte stem cells
05/08/2003WO2003038071A1 Detection of haematopoietic stem cells and progeny and uses thereof
05/08/2003WO2003038068A1 Lactic acid producing bacteria for use as probiotic organisms in the human vagina
05/08/2003WO2003038063A2 Human secreted proteins
05/08/2003WO2003038062A2 Generation of use of tc1 and tc2 cells
05/08/2003WO2003038058A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
05/08/2003WO2003038048A2 Ex-vivo rescue of transplantable hematopoietic stem cells following myeloablative injury
05/08/2003WO2003038043A2 Combinations of dr5 antibody and other therapeutic agents
05/08/2003WO2003038037A2 Glycogen synthase kinase function in endothelial cells
05/08/2003WO2003037922A1 Analgesic antitumor peptide from scorpion and method of producing it
05/08/2003WO2003037378A1 Method of preventing development of severe metabolic derangement in inborn errors of metabolism
05/08/2003WO2003037375A1 Cytokine-inducing material and cytokine-inducing instrument
05/08/2003WO2003037360A1 Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract
05/08/2003WO2003037320A1 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect
05/08/2003WO2003037260A2 Methods and compositions for treating parkinson's disease
05/08/2003WO2003037247A2 Methods and pharmaceutical compositions for dopaminergic modulation of t-cell adhesion and acitivty
05/08/2003WO2003037060A2 Compositions and methods for wt1 specific immunotherapy
05/08/2003WO2003018040A9 Composite graft for treatment of retinal diseases
05/08/2003WO2002102305B1 Adjuvant composition for mucosal and injection delivered vaccines
05/08/2003WO2002059279A3 Preparation of replicating kupffer cells and their use in diagnosis and therapy
05/08/2003WO2001091763A9 Extracts from spermatophyte plants with antitumor activity
05/08/2003US20030087985 Gels for encapsulation of biological materials
05/08/2003US20030087868 Administration of a vector to cells in vivo comprising and expressing a transgene encoding beta-glucosidase, the vector is taken up by the cells, the transgene is expressed therein and and beta-glucosidase is produced
05/08/2003US20030087859 Therapy for vision defects, central nervous system disorders; retinal pigment epithelium; genetic engineering
05/08/2003US20030087830 Low molecular weight components of cartilage, complexes of metals with amino acids, DI-peptides and analogs thereof; processes for preparation and therapeutic uses thereof
05/08/2003US20030087821 Using exendrin, or antagonist thereof; appetite control
05/08/2003US20030087817 Regulation of endogenous gene expression in cells using zinc finger proteins
05/08/2003US20030087433 Activator protein for use in cell propagation and cosmetics
05/08/2003US20030087428 Prepartion of soft tissue graft for implantation into a mammals; obtain tissue, expose to enzymes and detergents, wash, recover tissue graft, immerse in storage solution
05/08/2003US20030087384 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment fibroblast growth factor receptor defects
05/08/2003US20030087264 Detection of regulatory response to pulsatile electromagnetic stimulus; obtain tissue sample, insert probe, apply pulsatile stimulus, detect gene expression, classify genes which are expresed
05/08/2003US20030087246 Nucleic acids of the human ABCA12 gene, vectors containing such nucleic acids and uses thereof
05/08/2003US20030086961 Composition and method
05/08/2003US20030086949 Preparing a substrate containing triacylglycerol; placing in contact with a substance potentially active in the field of lipolysis and with lipoprotein lipase, in the presence of a cofactor to release fatty acid of triacylglycerol; analysis
05/08/2003US20030086938 Effecting presentation to the animal's immune system of an immunogenically effective amount of at least one analogue of autologous beta amyloid (A beta ) protein or autologous amyloid precursor
05/08/2003US20030086932 For use in downmodulation or upmodulation of the immune response; for preparing an allogeinc cell for transplantation
05/08/2003US20030086915 Embryonic stem cells, clinical applications and methods for expanding in vitro
05/08/2003US20030086914 Method and device for inducing biological processes by micro-organs
05/08/2003US20030086910 Hepatoblasts and method of isolating same
05/08/2003US20030086909 Composition and method for improving function of embryonic kidney transplants
05/08/2003US20030086908 Inoculating a mycelial inoculum of an isolate of Antrodia camphorata; subjecting culture cultivated to first stage of agitation to obtain second culture proliferation with mycelium; agitation to subject isolate to physiological stress
05/08/2003US20030086904 Therapeutic regimen for treating cancer
05/08/2003US20030086903 Therapeutic regimen for treating cancer
05/08/2003CA2465653A1 Method for inducing differentiation of mesodermal stem cells, es cells, or immortalized mesodermal stem cells into neural cells
05/08/2003CA2465314A1 Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents
05/08/2003CA2464956A1 Detection of haematopoietic stem cells and progeny and uses thereof
05/08/2003CA2464945A1 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect
05/08/2003CA2464889A1 Cytokine-inducing material and cytokine-inducing instrument
05/08/2003CA2464887A1 Methods and compositions for treating parkinson's disease
05/08/2003CA2464196A1 Method for enhancing keratinocyte stem cells
05/08/2003CA2463091A1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
05/08/2003CA2459178A1 Lactic acid producing bacteria for use as probiotic organisms in the human vagina
05/08/2003CA2441755A1 Human secreted proteins
05/07/2003EP1308172A1 Method for protein-preserving purification of contaminated biological liquids
05/07/2003EP1308170A2 Dried blood factor composition comprising trehalose
05/07/2003EP1308155A2 Injectable solution containing a colloid of iron and shark cartilage-derived chondroitin sulfate
05/07/2003EP1307557A2 Endothelial cell expression patterns
05/07/2003EP1307543A2 Autologous connective tissues, methods for the production thereof and their use
05/07/2003EP1307541A2 Tissue implant for cartilage repair
05/07/2003EP1307537A1 Neospora caninum isolate
05/07/2003EP1307246A1 Biomaterial including animal corneal tissue
05/07/2003EP1307241A1 Photodynamic treatment and uv-b irradiation of a thrombocyte suspension
05/07/2003EP1183035A4 Bone marrow transplantation for treatment of stroke